Eli Lilly and Novo Nordisk have both assuaged investor concerns over near-term growth. Now the focus shifts back to their ...
Subscribe to the Wake Up, cleveland.com’s free morning newsletter, delivered to your inbox weekdays at 5:30 a.m. Can you ...